A Phase II Study of VEGF Trap (NSC 724770) in Patients With Recurrent or Metastatic Transitional Carcinoma of the Urothelium
Phase of Trial: Phase II
Latest Information Update: 22 Oct 2016
At a glance
- Drugs Aflibercept (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- 18 May 2010 Actual end date (1 Apr 2010) added as reported by ClinicalTrials.gov.
- 18 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Sep 2008 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov.